Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Rigel Pharmaceuticals
(NQ:
RIGL
)
27.88
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Rigel Pharmaceuticals
< Previous
1
2
3
4
5
Next >
Earnings Scheduled For May 3, 2022
May 03, 2022
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.
Via
Benzinga
Earnings Scheduled For March 1, 2022
March 01, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...
Via
Benzinga
Earnings Scheduled For November 2, 2021
November 02, 2021
Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion. •...
Via
Benzinga
Understanding Rigel Pharmaceuticals's Unusual Options Activity
August 10, 2021
Rigel Pharmaceuticals (NASDAQ:RIGL) shares experienced un...
Via
Benzinga
Preview: Rigel Pharmaceuticals's Earnings
May 02, 2022
Rigel Pharmaceuticals (NASDAQ:RIGL) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Rigel...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2022
March 23, 2022
Upgrades For E2open Parent Holdings Inc (NYSE:ETWO), Colliers Securities upgraded the previous rating of Neutral to Buy. At the moment, the stock has a 52-week-high of $14.58 and...
Via
Benzinga
Looking Into Rigel Pharmaceuticals's Return On Capital Employed
March 07, 2022
Rigel Pharmaceuticals (NASDAQ:RIGL) brought in sales totaling $20.41 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 8.06%, resulting in...
Via
Benzinga
Recap: Rigel Pharmaceuticals Q4 Earnings
March 01, 2022
Rigel Pharmaceuticals (NASDAQ:RIGL) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
68 Biggest Movers From Yesterday
March 03, 2022
Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 39.2% to...
Via
Benzinga
Rigel Pharmaceuticals's Earnings Outlook
February 28, 2022
Rigel Pharmaceuticals (NASDAQ:RIGL) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement....
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
January 14, 2022
During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
November 22, 2021
Welcome back, traders! We're getting right into the week with a breakdown of the biggest pre-market stock movers for Monday!
Via
InvestorPlace
Exposures
Product Safety
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 03, 2021
Gainers Glaukos (NYSE:GKOS) stock increased by 25.55% to $56.58 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.6 billion...
Via
Benzinga
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...
Via
Benzinga
Topics
Retirement
Exposures
Pension
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 03, 2021
Good morning, trader! We're starting the day off right with a dive into the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
25 Stocks Moving in Wednesday's Pre-Market Session
November 03, 2021
Gainers Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 56.4% to $26.20 in pre-market trading on the heels of three new announcements from the company outlining strategic plans to...
Via
Benzinga
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Investor Alert: Investigation over Potential Wrongdoing
September 27, 2021
San Diego, CA -- (SBWIRE) -- 09/27/2021 -- Certain directors of Rigel Pharmaceuticals, Inc. are under investigation over possible breaches of fiduciary duties.
Via
SBWire
Exposures
COVID-19
NASDAQ:RIGL Shareholder Notice: Investigation over Possible Securities Laws Violations by Rigel Pharmaceuticals, Inc.
August 30, 2021
San Diego, CA -- (SBWIRE) -- 08/30/2021 -- An investigation was announced over potential securities laws violations by Rigel Pharmaceuticals, Inc. in connection with certain financial statements.
Via
SBWire
Exposures
COVID-19
Why Did the FDA Reject Rigel's EUA Application for Its COVID-19 Therapy?
August 26, 2021
More data is needed.
Via
The Motley Fool
Exposures
COVID-19
Product Safety
12 Health Care Stocks Moving In Friday's Intraday Session
August 13, 2021
Gainers Biolase (NASDAQ:BIOL) stock increased by 38.01% to $0.87 during Friday's regular session. Trading volume for this security as of 12:35 EST is 80.8 million,...
Via
Benzinga
Rigel Stock Falls After Update From COVID-19 Program
August 13, 2021
The FDA has informed Rigel Pharmaceuticals Inc (NASDAQ: RIGL) that data submitted in May from fostamatinib Phase 2 trial for COVID-19 is insufficient for an...
Via
Benzinga
Exposures
COVID-19
Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 13, 2021
Gainers Biolase (NASDAQ:BIOL) stock moved upwards by 42.49% to $0.9 during Friday's pre-market session. The company's market cap stands at $135.3 million. As per...
Via
Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
August 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
Earnings Scheduled For August 3, 2021
August 03, 2021
Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter. • Stellantis (NYSE:STLA) is expected to...
Via
Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....
Via
Benzinga
Exposures
Product Safety
Rigel's Fostamatinib Selected for NIH ACTIV-4 COVID-19 Trial
June 29, 2021
Rigel Pharmaceuticals Inc's (NASDAQ: RIGL) fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor, has been selected for a National Institutes of Health...
Via
Benzinga
Exposures
COVID-19
62 Biggest Movers From Yesterday
May 13, 2021
Gainers Curis, Inc. (NASDAQ: CRIS) shares surged 65.5% to settle at $16.27 on Wednesday in reaction to updated data from its ongoing open-label, single-arm, Phase 1/2 study of CA...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 12, 2021
Gainers Curis (NASDAQ:CRIS) shares moved upwards by 57.23% to $15.46 during Wednesday's regular session. Trading volume for Curis's stock is 28.8 million as of 12:...
Via
Benzinga
Cramer Advises Viewers On American Airlines, Luminar Technologies And More
May 10, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said he likes Calix Inc (NYSE: CALX), but he recommended Comcast Corporation (NASDAQ: CMCSA) instead. Esports...
Via
Benzinga
32 Stocks Moving in Friday's Pre-Market Session
May 07, 2021
Gainers Assertio Holdings, Inc. (NASDAQ: ASRT) shares rose 44.2% to $0.7190 in pre-market trading after the company reported better-than-expected Q1 results. iBio, Inc. (NYSE:...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.